Skip to main content

Advertisement

Table 1 Patients and the data types for the cohorts: SEQC, Versteeg, TARGET

From: Predicting clinical outcomes in neuroblastoma with genomic data integration

  SEQC Versteeg TARGET
# of patients 498 88 247
HR=1/HR=0 175/323 36/52 217/30
OS=1/OS=0 105/393 30/58 140/107
EFS=1/EFS=0 183/315 34/54 156/91
MYCN amp. / not amp. 92/401 16/72 68/175
  1. Note that our HR definition is based on Children’s Oncology Group. The number of total patients do not add up to 498 for MYCN amplification label as there is missing data